FPR1 and arthritic joint disease: Notably, activation of FPR2 and the homologue receptor FPR1 has shown therapeutic benefit against disease symptoms in K/BxN serum transfer-induced arthritis (STIA) (Dufton et al, 2010; Kao et al, 2014).